Dolby Laboratories Key Executives
This section highlights Dolby Laboratories's key executives, including their titles and compensation details.
Find Contacts at Dolby Laboratories
(Showing 0 of )
Dolby Laboratories Earnings
This section highlights Dolby Laboratories's earnings, including key dates, EPS, earnings reports, and earnings call transcripts.
Next Earnings Date
Date:
May 01, 2025
Time:
After Market
Est. EPS:
$1.29
Status:
Unconfirmed
Last Earnings Results
Date:
January 29, 2025
EPS:
$1.14
Est. EPS:
$1.07
Revenue:
$357.00M
Earnings Call Transcripts
| Transcript | Quarter | Year | Date | Estimated EPS | Actual EPS |
|---|---|---|---|---|---|
| Read Transcript | Q1 | 2025 | 2025-01-29 | $1.07 | $1.14 |
| Read Transcript | Q4 | 2024 | 2024-11-19 | $0.70 | $0.81 |
| Read Transcript | Q3 | 2024 | 2024-08-07 | $0.59 | $0.71 |
| Read Transcript | Q2 | 2024 | 2024-05-02 | $1.19 | $1.27 |
| Read Transcript | Q1 | 2024 | 2024-02-01 | $0.89 | $1.01 |
| Read Transcript | Q4 | 2023 | 2023-11-16 | $0.52 | $0.65 |
| Read Transcript | Q3 | 2023 | 2023-08-03 | $0.55 | $0.55 |
| Read Transcript | Q2 | 2023 | 2023-05-06 | N/A | N/A |
| Read Transcript | Q1 | 2023 | 2023-02-02 | $0.79 | $1.11 |
Dolby Laboratories, Inc. creates audio and imaging technologies that transform entertainment and communications at the cinema, DTV, transmissions and devices, mobile devices, OTT video and music services, and home entertainment devices. The company develops and licenses its audio technologies, such as AAC & HE-AAC, a digital audio codec solution used for a range of media applications.; AVC, a digital video codec with high bandwidth efficiency used in various media devices; Dolby AC-4, an digital audio coding technology that delivers new audio experiences to a range of playback devices; and Dolby Atmos technology for cinema and a range of media devices. Its audio technologies also include Dolby Digital, a digital audio coding technology that provides multichannel sound to applications; Dolby Digital Plus, a digital audio coding technology that offers audio transmission for a range of media applications and devices; Dolby TrueHD, a digital audio coding technology providing encoding for media application; Dolby Vision, an imaging technology for cinema and media devices; Dolby Voice, an audio conferencing technology; and HEVC, a digital video codec with high bandwidth efficiency to support for media devices. In addition, the company designs and manufactures digital cinema servers, cinema processors, amplifiers, loudspeakers, hardware components, video conferencing solutions, and other products for the cinema, television, broadcast, communication, and entertainment industries. Further, it offers various services to support theatrical and television production for cinema exhibition, broadcast, and home entertainment. The company serves film studios, content creators, post-production facilities, cinema operators, broadcasters, and video game designers. It sells its products directly to the end users, as well as through dealers and distributors worldwide. Dolby Laboratories, Inc. was founded in 1965 and is headquartered in San Francisco, California.
Technology
Information Technology Services
$76.02
Stock Price
$7.33B
Market Cap
2.08K
Employees
San Francisco, CA
Location
Financial Statements
Access annual & quarterly financial statements for Dolby Laboratories, including income statements, balance sheets, and cash flow statements..
Annual Income Statement
| Breakdown | September 27, 2024 | June 30, 2023 | September 30, 2022 | September 24, 2021 | September 25, 2020 |
|---|---|---|---|---|---|
| Revenue | $1.27B | $1.01B | $1.25B | $1.28B | $1.16B |
| Cost of Revenue | $140.50M | $117.01M | $141.36M | $130.03M | $146.50M |
| Gross Profit | $1.13B | $892.17M | $1.11B | $1.15B | $1.02B |
| Gross Profit Ratio | 88.97% | 88.41% | 88.73% | 89.85% | 87.39% |
| Research and Development Expenses | $263.66M | $201.10M | $261.17M | $253.64M | $239.04M |
| General and Administrative Expenses | $270.39M | $191.87M | $275.31M | $224.16M | $219.75M |
| Selling and Marketing Expenses | $334.46M | $263.49M | $358.72M | $332.67M | $335.93M |
| Selling General and Administrative Expenses | $604.85M | $455.36M | $634.03M | $556.83M | $555.69M |
| Other Expenses | $- | $- | $2.50M | $7.11M | $8.43M |
| Operating Expenses | $868.51M | $656.46M | $895.21M | $810.47M | $794.73M |
| Cost and Expenses | $1.01B | $773.47M | $1.04B | $940.50M | $941.23M |
| Interest Income | $- | $- | $6.57M | $3.49M | $12.72M |
| Interest Expense | $34.08M | $- | $394.00K | $479.00K | $186.00K |
| Depreciation and Amortization | $87.33M | $71.26M | $123.30M | $119.73M | $113.86M |
| EBITDA | $258.33M | $219.25M | $329.90M | $464.12M | $332.60M |
| EBITDA Ratio | 20.28% | 21.73% | 26.31% | 36.22% | 28.63% |
| Operating Income | $258.33M | $219.25M | $206.60M | $344.39M | $218.74M |
| Operating Income Ratio | 20.28% | 21.73% | 16.48% | 26.88% | 18.83% |
| Total Other Income Expenses Net | $54.15M | $21.77M | $8.67M | $10.12M | $20.97M |
| Income Before Tax | $312.48M | $241.02M | $215.28M | $354.51M | $239.72M |
| Income Before Tax Ratio | 24.53% | 23.88% | 17.17% | 27.67% | 20.63% |
| Income Tax Expense | $-48.16M | $-49.28M | $31.38M | $36.69M | $8.10M |
| Net Income | $360.64M | $191.47M | $184.09M | $310.23M | $231.36M |
| Net Income Ratio | 28.31% | 18.97% | 14.68% | 24.21% | 19.91% |
| EPS | $3.77 | $2.00 | $1.84 | $3.07 | $2.30 |
| EPS Diluted | $3.71 | $1.96 | $1.81 | $2.97 | $2.25 |
| Weighted Average Shares Outstanding | 95.54M | 95.79M | 99.99M | 101.19M | 100.56M |
| Weighted Average Shares Outstanding Diluted | 97.33M | 97.59M | 101.98M | 104.62M | 102.94M |
| SEC Filing | Source | Source | Source | Source | Source |
| Breakdown | September 27, 2024 | June 28, 2024 | March 29, 2024 | December 29, 2023 | September 29, 2023 | June 30, 2023 | March 31, 2023 | December 30, 2022 | September 30, 2022 | July 01, 2022 | April 01, 2022 | December 31, 2021 | September 24, 2021 | June 25, 2021 | March 26, 2021 | December 25, 2020 | September 25, 2020 | June 26, 2020 | March 27, 2020 | December 27, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $304.81M | $288.82M | $364.52M | $315.57M | $290.56M | $298.37M | $375.89M | $334.92M | $278.20M | $289.58M | $334.37M | $351.63M | $285.02M | $286.80M | $319.56M | $389.87M | $271.19M | $246.91M | $351.81M | $291.88M |
| Cost of Revenue | $34.00M | $35.66M | $38.78M | $32.06M | $35.55M | $41.52M | $41.05M | $34.45M | $37.18M | $35.96M | $35.52M | $32.71M | $30.70M | $31.64M | $32.38M | $35.30M | $42.47M | $29.89M | $36.83M | $37.31M |
| Gross Profit | $270.81M | $253.16M | $325.75M | $283.51M | $255.01M | $256.86M | $334.84M | $300.47M | $241.03M | $253.63M | $298.86M | $318.92M | $254.33M | $255.16M | $287.18M | $354.57M | $228.73M | $217.02M | $314.99M | $254.56M |
| Gross Profit Ratio | 88.85% | 87.65% | 89.36% | 89.84% | 87.76% | 86.09% | 89.08% | 89.71% | 86.64% | 87.58% | 89.38% | 90.70% | 89.23% | 88.97% | 89.87% | 90.94% | 84.34% | 87.90% | 89.53% | 87.22% |
| Research and Development Expenses | $68.64M | $65.50M | $62.49M | $67.03M | $70.43M | $68.70M | $67.95M | $64.45M | $62.07M | $62.86M | $67.42M | $68.82M | $61.97M | $62.09M | $65.81M | $63.77M | $61.73M | $59.58M | $60.09M | $57.65M |
| General and Administrative Expenses | $- | $69.28M | $66.74M | $65.17M | $66.61M | $69.95M | $61.94M | $59.97M | $57.06M | $57.11M | $98.69M | $62.44M | $54.19M | $56.12M | $59.40M | $54.45M | $55.58M | $50.84M | $60.80M | $52.53M |
| Selling and Marketing Expenses | $- | $77.52M | $90.04M | $79.00M | $90.87M | $85.59M | $95.69M | $82.20M | $90.20M | $87.11M | $84.23M | $97.17M | $98.47M | $80.71M | $78.05M | $75.44M | $81.40M | $70.93M | $88.48M | $95.12M |
| Selling General and Administrative Expenses | $154.37M | $146.79M | $156.78M | $144.17M | $157.48M | $155.55M | $157.63M | $142.18M | $147.27M | $144.23M | $182.92M | $159.61M | $152.66M | $136.83M | $137.44M | $129.90M | $136.98M | $121.78M | $149.28M | $147.65M |
| Other Expenses | $2.74M | $4.08M | $-2.50M | $6.09M | $3.25M | $620.00K | $1.25M | $1.10M | $667.00K | $2.51M | $-910.00K | $229.00K | $2.00M | $2.40M | $1.39M | $1.33M | $3.98M | $3.31M | $138.00K | $1.00M |
| Operating Expenses | $225.75M | $216.37M | $216.78M | $217.29M | $227.91M | $224.24M | $225.59M | $206.63M | $209.34M | $207.09M | $250.34M | $228.44M | $214.62M | $198.92M | $203.25M | $193.67M | $198.70M | $181.36M | $209.37M | $205.30M |
| Cost and Expenses | $259.74M | $252.03M | $255.56M | $249.35M | $263.46M | $265.76M | $266.63M | $241.08M | $246.52M | $243.04M | $285.86M | $261.15M | $245.32M | $230.57M | $235.63M | $228.97M | $241.17M | $211.25M | $246.20M | $242.61M |
| Interest Income | $6.85M | $- | $8.60M | $- | $- | $7.32M | $6.81M | $4.88M | $3.34M | $1.42M | $1.10M | $716.00K | $816.00K | $741.00K | $962.00K | $974.00K | $494.00K | $2.58M | $4.72M | $4.93M |
| Interest Expense | $- | $- | $- | $- | $- | $114.00K | $34.00M | $81.00K | $139.00K | $84.00K | $87.00K | $84.00K | $119.00K | $108.00K | $167.00K | $85.00K | $55.00K | $34.00K | $25.00K | $72.00K |
| Depreciation and Amortization | $14.67M | $21.21M | $20.78M | $20.96M | $24.26M | $24.30M | $24.59M | $28.09M | $22.57M | $32.16M | $31.71M | $27.42M | $42.06M | $23.30M | $25.23M | $22.17M | $26.98M | $23.69M | $19.97M | $20.24M |
| EBITDA | $59.73M | $62.07M | $127.25M | $93.27M | $81.95M | $64.85M | $109.29M | $122.18M | $35.69M | $77.73M | $75.06M | $118.85M | $42.51M | $82.67M | $111.51M | $185.37M | $34.50M | $65.23M | $130.45M | $75.44M |
| EBITDA Ratio | 19.60% | 21.49% | 34.91% | 29.56% | 28.21% | 21.74% | 29.07% | 36.48% | 12.83% | 26.84% | 22.45% | 33.80% | 14.92% | 28.83% | 34.89% | 47.55% | 12.72% | 26.42% | 37.08% | 25.85% |
| Operating Income | $45.06M | $36.78M | $108.97M | $66.22M | $-3.49M | $15.94M | $84.70M | $94.09M | $13.12M | $45.57M | $43.35M | $90.58M | $40.37M | $56.09M | $83.19M | $164.75M | $30.07M | $34.14M | $105.94M | $48.59M |
| Operating Income Ratio | 14.78% | 12.74% | 29.89% | 20.98% | -1.20% | 5.34% | 22.53% | 28.09% | 4.72% | 15.73% | 12.96% | 25.76% | 14.16% | 19.56% | 26.03% | 42.26% | 11.09% | 13.83% | 30.11% | 16.65% |
| Total Other Income Expenses Net | $14.67M | $13.38M | $12.78M | $14.61M | $-27.35M | $-16.06M | $32.58M | $5.89M | $17.85M | $3.85M | $101.00K | $324.00K | $2.66M | $2.26M | $644.00K | $5.17M | $4.03M | $1.78M | $469.00K | $329.00K |
| Income Before Tax | $59.73M | $50.16M | $121.75M | $80.83M | $9.03M | $23.76M | $117.28M | $99.98M | $30.97M | $49.41M | $43.45M | $91.44M | $43.06M | $59.12M | $85.37M | $166.96M | $34.49M | $39.99M | $110.78M | $54.45M |
| Income Before Tax Ratio | 19.60% | 17.37% | 33.40% | 25.61% | 3.11% | 7.96% | 31.20% | 29.85% | 11.13% | 17.06% | 12.99% | 26.00% | 15.11% | 20.62% | 26.71% | 42.82% | 12.72% | 16.20% | 31.49% | 18.66% |
| Income Tax Expense | $868.00K | $10.51M | $23.53M | $13.25M | $-875.00K | $7.35M | $21.40M | $20.53M | $3.21M | $9.80M | $6.93M | $11.43M | $-1.17M | $4.57M | $9.02M | $24.27M | $7.52M | $-27.39M | $22.11M | $5.86M |
| Net Income | $58.57M | $38.44M | $97.83M | $66.98M | $9.19M | $16.40M | $95.70M | $79.38M | $27.76M | $39.60M | $36.72M | $80.01M | $44.19M | $54.62M | $76.22M | $135.20M | $26.83M | $67.28M | $88.50M | $48.75M |
| Net Income Ratio | 19.22% | 13.31% | 26.84% | 21.23% | 3.16% | 5.50% | 25.46% | 23.70% | 9.98% | 13.67% | 10.98% | 22.75% | 15.50% | 19.05% | 23.85% | 34.68% | 9.89% | 27.25% | 25.15% | 16.70% |
| EPS | $1.23 | $0.40 | $1.02 | $0.70 | $0.10 | $0.17 | $1.00 | $0.83 | $0.29 | $0.40 | $0.36 | $0.79 | $0.44 | $0.54 | $0.75 | $1.34 | $0.27 | $0.67 | $0.88 | $0.49 |
| EPS Diluted | $1.21 | $0.40 | $1.01 | $0.69 | $0.09 | $0.17 | $0.98 | $0.82 | $0.28 | $0.39 | $0.36 | $0.77 | $0.42 | $0.52 | $0.73 | $1.30 | $0.26 | $0.66 | $0.86 | $0.47 |
| Weighted Average Shares Outstanding | 95.39M | 95.69M | 95.72M | 95.38M | 95.70M | 95.66M | 95.82M | 95.91M | 97.08M | 100.21M | 101.34M | 101.23M | 101.23M | 101.35M | 101.46M | 100.72M | 100.47M | 100.59M | 100.85M | 100.34M |
| Weighted Average Shares Outstanding Diluted | 96.59M | 96.96M | 96.86M | 97.44M | 97.68M | 97.46M | 97.30M | 97.05M | 98.46M | 101.47M | 102.71M | 103.80M | 104.37M | 104.63M | 104.58M | 103.88M | 102.72M | 102.08M | 102.77M | 103.08M |
| SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Annual Balance Sheet
| Breakdown | September 27, 2024 | September 29, 2023 | September 30, 2022 | September 24, 2021 | September 25, 2020 |
|---|---|---|---|---|---|
| Cash and Cash Equivalents | $482.05M | $745.36M | $620.13M | $1.23B | $1.07B |
| Short Term Investments | $- | $139.15M | $189.21M | $38.84M | $46.95M |
| Cash and Short Term Investments | $482.05M | $884.51M | $809.34M | $1.26B | $1.12B |
| Net Receivables | $315.46M | $444.38M | $419.69M | $414.93M | $341.70M |
| Inventory | $33.73M | $35.62M | $23.55M | $10.96M | $25.55M |
| Other Current Assets | $363.18M | $50.69M | $23.22M | $62.74M | $53.02M |
| Total Current Assets | $1.19B | $1.49B | $1.31B | $1.76B | $1.55B |
| Property Plant Equipment Net | $518.15M | $521.78M | $560.01M | $601.51M | $618.48M |
| Goodwill | $533.21M | $408.41M | $365.15M | $340.69M | $489.38M |
| Intangible Assets | $434.51M | $167.43M | $112.27M | $122.89M | $152.43M |
| Goodwill and Intangible Assets | $967.72M | $575.84M | $477.41M | $463.58M | $489.38M |
| Long Term Investments | $89.27M | $97.81M | $102.51M | $62.82M | $52.15M |
| Tax Assets | $219.76M | $201.86M | $183.57M | $156.02M | $118.88M |
| Other Non-Current Assets | $120.61M | $94.67M | $55.15M | $61.26M | $91.25M |
| Total Non-Current Assets | $1.92B | $1.49B | $1.38B | $1.35B | $1.37B |
| Other Assets | $- | $- | $- | $- | $- |
| Total Assets | $3.11B | $2.98B | $2.69B | $3.11B | $2.92B |
| Account Payables | $17.38M | $20.93M | $14.17M | $17.78M | $12.62M |
| Short Term Debt | $12.24M | $13.63M | $13.26M | $15.40M | $15.82M |
| Tax Payables | $9.04M | $4.77M | $1.26M | $1.33M | $3.26M |
| Deferred Revenue | $- | $31.50M | $18.59M | $18.47M | $15.44M |
| Other Current Liabilities | $379.17M | $330.47M | $216.07M | $244.95M | $207.36M |
| Total Current Liabilities | $417.84M | $422.23M | $277.52M | $315.72M | $267.11M |
| Long Term Debt | $69.51M | $37.02M | $37.69M | $56.72M | $65.31M |
| Deferred Revenue Non-Current | $- | $40.00M | $23.20M | $23.71M | $24.34M |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- |
| Other Non-Current Liabilities | $156.38M | $108.34M | $100.12M | $105.31M | $122.15M |
| Total Non-Current Liabilities | $225.88M | $185.36M | $161.01M | $185.74M | $211.81M |
| Other Liabilities | $-20.68M | $- | $- | $- | $- |
| Total Liabilities | $623.03M | $607.58M | $438.53M | $501.45M | $478.92M |
| Preferred Stock | $- | $36.98M | $- | $- | $- |
| Common Stock | $- | $94.00K | $94.00K | $100.00K | $99.00K |
| Retained Earnings | $2.50B | $2.39B | $2.30B | $2.61B | $2.44B |
| Accumulated Other Comprehensive Income Loss | $-19.19M | $-36.98M | $-51.64M | $-10.03M | $-10.59M |
| Other Total Stockholders Equity | $94.00K | $- | $- | $- | $- |
| Total Stockholders Equity | $2.48B | $2.36B | $2.25B | $2.60B | $2.43B |
| Total Equity | $2.49B | $2.37B | $2.25B | $2.60B | $2.43B |
| Total Liabilities and Stockholders Equity | $3.11B | $2.98B | $2.69B | $3.11B | $2.92B |
| Minority Interest | $9.73M | $17.08M | $4.84M | $6.25M | $5.76M |
| Total Liabilities and Total Equity | $3.11B | $2.98B | $2.69B | $3.11B | $2.92B |
| Total Investments | $89.27M | $236.96M | $291.73M | $101.66M | $99.10M |
| Total Debt | $46.99M | $50.65M | $50.94M | $72.12M | $81.14M |
| Net Debt | $-435.06M | $-694.72M | $-569.18M | $-1.15B | $-990.74M |
Balance Sheet Charts
| Breakdown | September 27, 2024 | June 28, 2024 | March 29, 2024 | December 29, 2023 | September 29, 2023 | June 30, 2023 | March 31, 2023 | December 30, 2022 | September 30, 2022 | July 01, 2022 | April 01, 2022 | December 31, 2021 | September 24, 2021 | June 25, 2021 | March 26, 2021 | December 25, 2020 | September 25, 2020 | June 26, 2020 | March 27, 2020 | December 27, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash and Cash Equivalents | $577.75M | $741.64M | $709.53M | $656.82M | $745.36M | $765.08M | $688.44M | $626.16M | $620.13M | $858.90M | $900.39M | $1.06B | $1.23B | $1.22B | $1.10B | $1.11B | $1.07B | $855.10M | $724.93M | $741.43M |
| Short Term Investments | $- | $127.32M | $115.86M | $140.82M | $139.15M | $124.21M | $126.39M | $132.88M | $189.21M | $156.81M | $141.69M | $80.62M | $38.84M | $48.28M | $58.58M | $52.26M | $46.95M | $189.38M | $174.86M | $170.23M |
| Cash and Short Term Investments | $577.75M | $868.96M | $825.40M | $797.64M | $884.51M | $889.29M | $814.84M | $759.03M | $809.34M | $1.02B | $1.04B | $1.14B | $1.26B | $1.27B | $1.16B | $1.16B | $1.12B | $1.04B | $899.79M | $911.66M |
| Net Receivables | $512.94M | $476.65M | $525.30M | $510.79M | $444.38M | $459.45M | $558.58M | $505.52M | $419.69M | $406.63M | $486.11M | $468.26M | $414.93M | $441.66M | $516.88M | $481.49M | $341.70M | $375.95M | $470.78M | $396.64M |
| Inventory | $33.73M | $34.72M | $35.80M | $37.57M | $35.62M | $32.40M | $30.35M | $26.11M | $23.55M | $24.10M | $16.62M | $13.14M | $10.96M | $12.14M | $14.88M | $20.11M | $25.55M | $29.33M | $28.33M | $29.10M |
| Other Current Assets | $69.99M | $88.34M | $165.24M | $105.36M | $50.69M | $28.60M | $53.85M | $24.94M | $23.22M | $21.48M | $33.22M | $68.69M | $62.74M | $24.60M | $27.23M | $51.39M | $53.02M | $23.35M | $23.35M | $23.11M |
| Total Current Assets | $1.19B | $1.47B | $1.55B | $1.45B | $1.49B | $1.47B | $1.46B | $1.35B | $1.31B | $1.50B | $1.62B | $1.70B | $1.76B | $1.77B | $1.75B | $1.72B | $1.55B | $1.50B | $1.46B | $1.40B |
| Property Plant Equipment Net | $518.15M | $517.54M | $524.55M | $517.32M | $521.78M | $540.94M | $552.74M | $555.52M | $560.01M | $571.57M | $586.56M | $596.85M | $601.51M | $610.05M | $614.68M | $619.01M | $618.48M | $625.02M | $630.47M | $620.57M |
| Goodwill | $967.72M | $408.46M | $408.65M | $410.44M | $408.41M | $426.31M | $370.13M | $369.38M | $365.15M | $368.28M | $371.74M | $339.90M | $340.69M | $338.38M | $338.24M | $483.40M | $489.38M | $335.69M | $332.98M | $335.44M |
| Intangible Assets | $- | $144.64M | $152.15M | $159.89M | $167.43M | $177.33M | $98.88M | $105.91M | $112.27M | $119.25M | $126.28M | $125.80M | $122.89M | $129.21M | $136.94M | $144.69M | $152.43M | $160.07M | $167.92M | $175.98M |
| Goodwill and Intangible Assets | $967.72M | $553.10M | $560.80M | $570.33M | $575.84M | $603.64M | $469.01M | $475.30M | $477.41M | $487.53M | $498.02M | $465.70M | $463.58M | $467.60M | $475.18M | $483.40M | $489.38M | $495.76M | $500.90M | $511.42M |
| Long Term Investments | $89.27M | $117.90M | $127.97M | $92.88M | $97.81M | $98.10M | $100.80M | $124.02M | $102.51M | $106.73M | $124.14M | $120.99M | $62.82M | $54.16M | $42.19M | $49.34M | $52.15M | $74.77M | $127.29M | $141.72M |
| Tax Assets | $219.76M | $219.82M | $208.49M | $206.67M | $201.86M | $209.68M | $203.89M | $192.18M | $183.57M | $183.54M | $175.24M | $164.91M | $156.02M | $145.10M | $135.55M | $133.61M | $118.88M | $104.02M | $129.25M | $123.28M |
| Other Non-Current Assets | $120.61M | $96.62M | $71.17M | $96.98M | $94.67M | $86.21M | $47.10M | $52.08M | $55.15M | $65.84M | $57.46M | $61.33M | $61.26M | $85.36M | $87.55M | $86.83M | $91.25M | $100.90M | $97.35M | $95.28M |
| Total Non-Current Assets | $1.92B | $1.50B | $1.49B | $1.48B | $1.49B | $1.54B | $1.37B | $1.40B | $1.38B | $1.42B | $1.44B | $1.41B | $1.35B | $1.36B | $1.36B | $1.37B | $1.37B | $1.40B | $1.49B | $1.49B |
| Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Assets | $3.11B | $2.97B | $3.04B | $2.94B | $2.98B | $3.01B | $2.84B | $2.75B | $2.69B | $2.92B | $3.06B | $3.10B | $3.11B | $3.14B | $3.11B | $3.10B | $2.92B | $2.90B | $2.94B | $2.89B |
| Account Payables | $17.38M | $16.41M | $19.73M | $14.39M | $20.93M | $15.39M | $17.17M | $17.36M | $14.17M | $16.82M | $11.37M | $19.10M | $17.78M | $12.19M | $8.38M | $13.63M | $12.62M | $10.05M | $9.04M | $13.70M |
| Short Term Debt | $12.24M | $12.57M | $14.21M | $12.92M | $13.63M | $13.51M | $12.62M | $13.20M | $13.26M | $14.33M | $15.41M | $15.31M | $15.40M | $15.64M | $15.31M | $15.82M | $15.82M | $16.32M | $17.41M | $15.60M |
| Tax Payables | $- | $12.29M | $8.38M | $6.19M | $4.77M | $11.02M | $14.50M | $7.18M | $1.26M | $3.85M | $3.52M | $1.60M | $1.33M | $7.90M | $11.09M | $15.52M | $3.26M | $3.07M | $15.19M | $2.32M |
| Deferred Revenue | $31.64M | $32.65M | $37.70M | $33.40M | $31.50M | $36.59M | $22.96M | $22.36M | $18.59M | $21.22M | $22.11M | $21.43M | $18.47M | $18.20M | $20.03M | $21.20M | $15.44M | $18.02M | $19.75M | $19.79M |
| Other Current Liabilities | $356.57M | $280.61M | $362.88M | $327.19M | $330.47M | $331.13M | $229.59M | $212.99M | $216.07M | $212.45M | $217.17M | $206.74M | $244.95M | $242.85M | $245.78M | $236.62M | $207.36M | $200.19M | $236.83M | $228.35M |
| Total Current Liabilities | $417.84M | $354.54M | $442.90M | $394.10M | $422.23M | $423.04M | $314.01M | $290.45M | $277.52M | $285.49M | $280.96M | $283.29M | $315.72M | $308.96M | $308.98M | $316.42M | $267.11M | $257.70M | $307.25M | $293.46M |
| Long Term Debt | $34.75M | $35.62M | $37.71M | $34.32M | $37.02M | $36.55M | $35.24M | $34.22M | $37.69M | $44.26M | $48.19M | $52.62M | $56.72M | $60.97M | $61.16M | $64.26M | $65.31M | $65.19M | $64.42M | $57.98M |
| Deferred Revenue Non-Current | $34.59M | $35.65M | $36.45M | $36.99M | $40.00M | $41.62M | $22.72M | $22.73M | $23.20M | $24.35M | $24.57M | $24.12M | $23.71M | $22.14M | $23.37M | $23.77M | $24.34M | $24.13M | $25.07M | $23.92M |
| Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $95.42M | $- | $- | $- | $- | $- | $- | $- | $90.42M | $92.67M | $- | $- | $81.70M | $140.82M | $141.95M |
| Other Non-Current Liabilities | $156.54M | $100.40M | $89.97M | $107.81M | $108.34M | $28.58M | $108.17M | $108.60M | $100.12M | $106.32M | $104.08M | $102.38M | $105.31M | $24.83M | $25.89M | $121.20M | $122.15M | $38.29M | $37.99M | $37.27M |
| Total Non-Current Liabilities | $225.88M | $171.67M | $164.14M | $179.12M | $185.36M | $202.18M | $166.13M | $165.55M | $161.01M | $174.93M | $176.84M | $179.11M | $185.74M | $198.36M | $203.09M | $209.22M | $211.81M | $209.31M | $268.30M | $261.12M |
| Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Total Liabilities | $643.72M | $526.20M | $607.04M | $573.22M | $607.58M | $625.22M | $480.14M | $456.00M | $438.53M | $460.41M | $457.80M | $462.40M | $501.45M | $507.32M | $512.07M | $525.64M | $478.92M | $467.01M | $575.56M | $554.58M |
| Preferred Stock | $- | $- | $- | $- | $36.98M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock | $94.00K | $94.00K | $94.00K | $94.00K | $94.00K | $94.00K | $95.00K | $95.00K | $94.00K | $98.00K | $99.00K | $100.00K | $100.00K | $100.00K | $100.00K | $100.00K | $99.00K | $99.00K | $99.00K | $99.00K |
| Retained Earnings | $2.50B | $2.46B | $2.45B | $2.37B | $2.39B | $2.40B | $2.38B | $2.32B | $2.30B | $2.48B | $2.62B | $2.65B | $2.61B | $2.63B | $2.59B | $2.57B | $2.44B | $2.45B | $2.40B | $2.35B |
| Accumulated Other Comprehensive Income Loss | $-19.19M | $-30.17M | $-29.07M | $-21.43M | $-36.98M | $-31.16M | $-27.43M | $-31.88M | $-51.64M | $-30.43M | $-15.68M | $-11.52M | $-10.03M | $-5.03M | $-4.04M | $-608.00K | $-10.59M | $-17.12M | $-31.61M | $-18.06M |
| Other Total Stockholders Equity | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $99.00K | $100.00K | $- | $100.00K | $100.00K | $100.00K | $- | $99.00K | $99.00K | $99.00K |
| Total Stockholders Equity | $2.48B | $2.43B | $2.42B | $2.35B | $2.36B | $2.37B | $2.35B | $2.29B | $2.25B | $2.45B | $2.60B | $2.64B | $2.60B | $2.62B | $2.59B | $2.57B | $2.43B | $2.43B | $2.36B | $2.33B |
| Total Equity | $2.49B | $2.45B | $2.44B | $2.36B | $2.37B | $2.37B | $2.35B | $2.29B | $2.25B | $2.45B | $2.60B | $2.64B | $2.60B | $2.62B | $2.59B | $2.57B | $2.43B | $2.43B | $2.36B | $2.33B |
| Total Liabilities and Stockholders Equity | $3.11B | $2.97B | $3.04B | $2.94B | $2.98B | $3.01B | $2.84B | $2.75B | $2.69B | $2.92B | $3.06B | $3.10B | $3.11B | $3.14B | $3.11B | $3.10B | $2.92B | $2.90B | $2.94B | $2.89B |
| Minority Interest | $9.73M | $14.58M | $16.79M | $16.46M | $17.08M | $16.48M | $5.21M | $4.95M | $4.84M | $5.16M | $5.42M | $4.77M | $6.25M | $6.30M | $6.29M | $6.05M | $5.76M | $5.53M | $5.22M | $5.41M |
| Total Liabilities and Total Equity | $3.11B | $2.97B | $3.04B | $2.94B | $2.98B | $3.01B | $2.84B | $2.75B | $2.69B | $2.92B | $3.06B | $3.10B | $3.11B | $3.14B | $3.11B | $3.10B | $2.92B | $2.90B | $2.94B | $2.89B |
| Total Investments | $89.27M | $245.22M | $243.84M | $233.70M | $236.96M | $222.31M | $227.19B | $256.90M | $291.73M | $263.54M | $265.83M | $201.61M | $101.66M | $102.43M | $100.77M | $101.60M | $99.10M | $264.15M | $302.15M | $311.95M |
| Total Debt | $46.99M | $48.19M | $51.92M | $47.24M | $50.65M | $50.06M | $47.87M | $47.42M | $50.94M | $58.59M | $63.60M | $67.93M | $72.12M | $76.61M | $76.48M | $80.07M | $81.14M | $81.51M | $81.84M | $73.59M |
| Net Debt | $-530.76M | $-693.45M | $-657.62M | $-609.58M | $-694.72M | $-715.01M | $-640.58M | $-578.74M | $-569.18M | $-800.32M | $-836.79M | $-988.76M | $-1.15B | $-1.14B | $-1.03B | $-1.03B | $-990.74M | $-773.60M | $-643.10M | $-667.84M |
Annual Cash Flow
| Breakdown | September 27, 2024 | June 30, 2023 | September 30, 2022 | September 24, 2021 | September 25, 2020 |
|---|---|---|---|---|---|
| Net Income | $261.82M | $191.74M | $183.90M | $317.82M | $231.62M |
| Depreciation and Amortization | $87.33M | $71.26M | $103.61M | $112.76M | $90.88M |
| Deferred Income Tax | $-21.61M | $-21.65M | $-29.46M | $-37.05M | $-5.27M |
| Stock Based Compensation | $119.83M | $90.29M | $114.92M | $99.70M | $86.63M |
| Change in Working Capital | $-101.34M | $-42.62M | $-56.25M | $-24.64M | $-81.05M |
| Accounts Receivables | $-28.97M | $43.55M | $-14.31M | $-49.03M | $1.25M |
| Inventory | $-2.65M | $-2.42M | $-11.76M | $17.15M | $-11.78M |
| Accounts Payables | $-34.55M | $-83.74M | $-33.54M | $44.23M | $-45.19M |
| Other Working Capital | $-35.16M | $42.62M | $3.36M | $-36.99M | $-25.33M |
| Other Non Cash Items | $-18.77M | $-6.95M | $1.86M | $-20.84M | $21.05M |
| Net Cash Provided by Operating Activities | $327.25M | $282.07M | $318.58M | $447.75M | $343.85M |
| Investments in Property Plant and Equipment | $-30.01M | $-22.15M | $-59.46M | $-54.45M | $-68.99M |
| Acquisitions Net | $-487.88M | $25.70M | $-38.17M | $-4.50M | $2.64M |
| Purchases of Investments | $-160.20M | $-123.08M | $-316.31M | $-67.10M | $-287.78M |
| Sales Maturities of Investments | $391.79M | $193.44M | $118.00M | $64.78M | $491.14M |
| Other Investing Activities | $- | $- | $- | $16.36M | $-2.64M |
| Net Cash Used for Investing Activities | $-286.29M | $73.92M | $-295.94M | $-44.91M | $134.37M |
| Debt Repayment | $-5.26M | $- | $- | $- | $- |
| Common Stock Issued | $40.20M | $37.23M | $57.85M | $122.09M | $82.66M |
| Common Stock Repurchased | $-199.08M | $-152.90M | $-566.90M | $-278.07M | $-196.81M |
| Dividends Paid | $-114.58M | $-77.58M | $-100.07M | $-89.17M | $-88.58M |
| Other Financing Activities | $-48.17M | $-766.00K | $-1.44M | $-7.36M | $-5.04M |
| Net Cash Used Provided by Financing Activities | $-287.81M | $-194.01M | $-610.56M | $-252.51M | $-207.78M |
| Effect of Forex Changes on Cash | $6.64M | $8.82M | $-16.74M | $2.72M | $3.94M |
| Net Change in Cash | $-240.21M | $170.79M | $-604.66M | $153.05M | $274.39M |
| Cash at End of Period | $577.75M | $799.16M | $628.37M | $1.23B | $1.08B |
| Cash at Beginning of Period | $817.97M | $628.37M | $1.23B | $1.08B | $805.59M |
| Operating Cash Flow | $327.25M | $282.07M | $318.58M | $447.75M | $343.85M |
| Capital Expenditure | $-30.01M | $-22.15M | $-59.46M | $-54.45M | $-68.99M |
| Free Cash Flow | $297.25M | $259.91M | $259.12M | $393.30M | $274.86M |
Cash Flow Charts
| Breakdown | September 27, 2024 | June 28, 2024 | March 29, 2024 | December 29, 2023 | September 29, 2023 | June 30, 2023 | March 31, 2023 | December 30, 2022 | September 30, 2022 | July 01, 2022 | April 01, 2022 | December 31, 2021 | September 24, 2021 | June 25, 2021 | March 26, 2021 | December 25, 2020 | September 25, 2020 | June 26, 2020 | March 27, 2020 | December 27, 2019 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income | $58.57M | $39.66M | $98.21M | $67.58M | $9.91M | $16.41M | $95.88M | $79.45M | $27.76M | $39.61M | $36.52M | $80.01M | $44.23M | $54.56M | $76.34M | $142.69M | $26.98M | $67.38M | $88.67M | $48.59M |
| Depreciation and Amortization | $- | $21.21M | $20.78M | $20.96M | $24.26M | $24.30M | $24.59M | $22.36M | $22.57M | $27.25M | $26.36M | $27.42M | $42.06M | $23.30M | $25.23M | $22.17M | $26.98M | $23.69M | $19.97M | $20.24M |
| Deferred Income Tax | $-3.60M | $-11.23M | $-1.38M | $-5.40M | $3.32M | $-2.11M | $-11.29M | $-8.26M | $-322.00K | $-9.78M | $-10.36M | $-9.00M | $-10.57M | $-9.49M | $-1.55M | $-15.44M | $-15.11M | $24.98M | $-5.97M | $-9.17M |
| Stock Based Compensation | $- | $29.34M | $28.91M | $31.89M | $28.20M | $29.22M | $29.83M | $31.24M | $26.96M | $27.61M | $27.70M | $32.66M | $24.14M | $24.84M | $24.41M | $26.31M | $21.78M | $21.29M | $20.95M | $22.61M |
| Change in Working Capital | $16.96M | $-52.27M | $35.85M | $-101.89M | $5.29M | $49.13M | $-32.43M | $-63.98M | $-26.64M | $90.59M | $-19.28M | $-100.94M | $14.08M | $80.73M | $-31.39M | $-88.06M | $44.25M | $-8.65M | $-64.32M | $-52.32M |
| Accounts Receivables | $-7.71M | $49.56M | $-15.18M | $-64.33M | $4.23M | $81.31M | $7.38M | $-45.15M | $-8.92M | $-8.89M | $13.46M | $-9.96M | $44.81M | $8.94M | $9.11M | $-111.90M | $65.50M | $-3.38M | $-58.54M | $-2.33M |
| Inventory | $1.96M | $3.22M | $1.46M | $-9.30M | $-10.80M | $2.30M | $-4.23M | $-501.00K | $472.00K | $-7.19M | $-3.23M | $-1.82M | $2.33M | $4.43M | $5.97M | $4.42M | $749.00K | $-7.16M | $-6.14M | $767.00K |
| Accounts Payables | $46.28M | $- | $- | $- | $42.25M | $-26.55M | $- | $5.76M | $-26.67M | $- | $-3.44M | $-34.03M | $12.44M | $4.86M | $4.65M | $22.27M | $3.11M | $-26.26M | $8.75M | $-30.79M |
| Other Working Capital | $-23.57M | $-105.04M | $49.58M | $-28.26M | $11.86M | $-7.93M | $-35.59M | $-24.09M | $8.48M | $106.67M | $-26.08M | $-55.12M | $-45.50M | $62.50M | $-51.13M | $-2.86M | $-25.11M | $28.14M | $-8.39M | $-19.97M |
| Other Non Cash Items | $44.24M | $-5.44M | $-970.00K | $-4.74M | $14.05M | $4.17M | $-2.04M | $-4.42M | $976.00K | $-2.68M | $2.05M | $1.51M | $-4.16M | $-1.59M | $-9.58M | $-5.51M | $7.79M | $5.62M | $6.43M | $1.21M |
| Net Cash Provided by Operating Activities | $116.17M | $21.26M | $181.41M | $8.41M | $85.02M | $121.13M | $104.54M | $56.40M | $51.31M | $172.61M | $63.00M | $31.66M | $109.77M | $172.35M | $83.47M | $82.16M | $112.66M | $134.29M | $65.74M | $31.16M |
| Investments in Property Plant and Equipment | $-7.38M | $-7.61M | $-8.92M | $-6.10M | $-8.19M | $-7.41M | $-7.52M | $-7.22M | $-10.71M | $-11.16M | $-11.70M | $-25.88M | $-11.84M | $-13.73M | $-13.36M | $-15.53M | $-10.44M | $-14.13M | $-20.75M | $-23.68M |
| Acquisitions Net | $-9.92M | $- | $- | $- | $11.53M | $25.70M | $- | $- | $-36.63M | $-769.00K | $- | $11.43M | $- | $- | $- | $- | $- | $- | $2.35M | $290.00K |
| Purchases of Investments | $-12.55M | $-43.51M | $-68.38M | $-35.75M | $-49.88M | $-42.51M | $-7.77M | $-72.79M | $-63.16M | $-46.92M | $-93.08M | $-113.15M | $-19.04M | $-21.62M | $-12.72M | $-13.73M | $-21.71M | $-98.77M | $-37.97M | $-129.32M |
| Sales Maturities of Investments | $246.50M | $43.38M | $59.42M | $42.48M | $38.35M | $46.26M | $38.88M | $108.31M | $33.15M | $50.70M | $21.25M | $12.91M | $20.41M | $21.16M | $11.82M | $11.39M | $186.78M | $139.85M | $48.91M | $115.59M |
| Other Investing Activities | $-477.96M | $- | $- | $- | $- | $- | $- | $- | $36.63M | $- | $-37.40M | $-11.43M | $-4.50M | $- | $- | $16.36M | $- | $- | $-2.35M | $-290.00K |
| Net Cash Used for Investing Activities | $-261.31M | $-7.74M | $-17.87M | $633.00K | $-19.71M | $22.03M | $23.59M | $28.30M | $-40.72M | $-8.16M | $-120.94M | $-126.11M | $-14.96M | $-14.19M | $-14.26M | $-1.50M | $154.63M | $26.95M | $-9.80M | $-37.41M |
| Debt Repayment | $-5.26M | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
| Common Stock Issued | $716.00K | $10.14M | $11.04M | $18.30M | $10.55M | $15.84M | $10.44M | $10.95M | $4.25M | $18.54M | $13.69M | $21.37M | $32.94M | $17.99M | $19.83M | $51.32M | $14.37M | $14.30M | $29.61M | $24.37M |
| Common Stock Repurchased | $-20.00M | $-36.37M | $-26.49M | $-114.56M | $-27.52M | $-26.82M | $-51.66M | $-74.41M | $-222.42M | $-191.27M | $-85.71M | $-67.49M | $-97.52M | $-40.56M | $-71.92M | $-68.07M | $-46.09M | $-27.96M | $-72.48M | $-50.28M |
| Dividends Paid | $-28.61M | $-28.70M | $-28.72M | $-28.55M | $-25.82M | $-25.84M | $-25.87M | $-25.87M | $-24.25M | $-25.14M | $-25.40M | $-25.28M | $-22.29M | $-22.31M | $-22.34M | $-22.23M | $-22.14M | $-22.10M | $-22.25M | $-22.08M |
| Other Financing Activities | $-6.96M | $-3.46M | $- | $-325.00K | $- | $- | $- | $-766.00K | $1.44M | $- | $- | $-1.44M | $- | $- | $- | $-7.36M | $- | $-1.67M | $-3.09M | $-283.00K |
| Net Cash Used Provided by Financing Activities | $-60.12M | $-58.40M | $-44.16M | $-125.14M | $-42.80M | $-36.83M | $-67.10M | $-90.09M | $-242.43M | $-197.87M | $-97.42M | $-72.84M | $-86.86M | $-44.88M | $-74.43M | $-46.34M | $-53.86M | $-37.43M | $-68.21M | $-48.28M |
| Effect of Forex Changes on Cash | $- | $-857.00K | $-3.68M | $6.79M | $-3.70M | $-596.00K | $911.00K | $8.50M | $-7.05M | $-8.16M | $-231.00K | $-1.31M | $-2.17M | $475.00K | $-709.00K | $5.12M | $3.15M | $5.14M | $-6.44M | $2.09M |
| Net Change in Cash | $- | $-45.73M | $115.70M | $-109.31M | $18.81M | $105.74M | $61.94M | $3.11M | $-238.89M | $-41.58M | $-155.59M | $-168.60M | $5.78M | $113.76M | $-5.93M | $39.45M | $216.59M | $128.95M | $-18.71M | $-52.44M |
| Cash at End of Period | $577.75M | $778.62M | $824.36M | $708.66M | $817.97M | $799.16M | $693.42M | $631.48M | $628.37M | $867.26M | $908.84M | $1.06B | $1.23B | $1.23B | $1.11B | $1.12B | $1.08B | $863.39M | $734.44M | $753.15M |
| Cash at Beginning of Period | $774.44M | $824.36M | $708.66M | $817.97M | $799.16M | $693.42M | $631.48M | $628.37M | $867.26M | $908.84M | $1.06B | $1.23B | $1.23B | $1.11B | $1.12B | $1.08B | $863.39M | $734.44M | $753.15M | $805.59M |
| Operating Cash Flow | $116.17M | $21.26M | $181.41M | $8.41M | $85.02M | $121.13M | $104.54M | $56.40M | $51.31M | $172.61M | $63.00M | $31.66M | $109.77M | $172.35M | $83.47M | $82.16M | $112.66M | $134.29M | $65.74M | $31.16M |
| Capital Expenditure | $-7.38M | $-7.61M | $-8.92M | $-6.10M | $-8.19M | $-7.41M | $-7.52M | $-7.22M | $-10.71M | $-11.16M | $-11.70M | $-25.88M | $-11.84M | $-13.73M | $-13.36M | $-15.53M | $-10.44M | $-14.13M | $-20.75M | $-23.68M |
| Free Cash Flow | $108.79M | $13.65M | $172.49M | $2.31M | $76.83M | $113.72M | $97.02M | $49.18M | $40.60M | $161.44M | $51.30M | $5.78M | $97.94M | $158.62M | $70.11M | $66.63M | $102.22M | $120.16M | $44.99M | $7.48M |
Dolby Laboratories Dividends
Explore Dolby Laboratories's dividend history, including dividend yield, payout ratio, and historical payments.
Dividend Yield
1.59%
Dividend Payout Ratio
31.77%
Dividend Paid & Capex Coverage Ratio
2.26x
Dolby Laboratories Dividend History
| Dividend | Adjusted Dividend | Date | Record Date | Payment Date | Declaration Date |
|---|---|---|---|---|---|
| $0.33 | $0.33 | February 11, 2025 | February 11, 2025 | February 19, 2025 | January 29, 2025 |
| $0.33 | $0.33 | December 03, 2024 | December 03, 2024 | December 10, 2024 | November 19, 2024 |
| $0.3 | $0.3 | August 19, 2024 | August 19, 2024 | August 27, 2024 | August 07, 2024 |
| $0.3 | $0.3 | May 13, 2024 | May 14, 2024 | May 22, 2024 | May 02, 2024 |
| $0.3 | $0.3 | February 12, 2024 | February 13, 2024 | February 22, 2024 | February 01, 2024 |
| $0.3 | $0.3 | November 27, 2023 | November 28, 2023 | December 05, 2023 | November 16, 2023 |
| $0.27 | $0.27 | August 11, 2023 | August 14, 2023 | August 22, 2023 | August 03, 2023 |
| $0.27 | $0.27 | May 15, 2023 | May 16, 2023 | May 23, 2023 | May 04, 2023 |
| $0.27 | $0.27 | February 13, 2023 | February 14, 2023 | February 22, 2023 | February 02, 2023 |
| $0.27 | $0.27 | November 29, 2022 | November 30, 2022 | December 08, 2022 | November 17, 2022 |
| $0.25 | $0.25 | August 22, 2022 | August 23, 2022 | August 31, 2022 | August 09, 2022 |
| $0.25 | $0.25 | May 16, 2022 | May 17, 2022 | May 25, 2022 | May 05, 2022 |
| $0.25 | $0.25 | February 15, 2022 | February 16, 2022 | February 23, 2022 | February 03, 2022 |
| $0.25 | $0.25 | November 29, 2021 | November 30, 2021 | December 08, 2021 | November 16, 2021 |
| $0.22 | $0.22 | August 10, 2021 | August 11, 2021 | August 19, 2021 | July 29, 2021 |
| $0.22 | $0.22 | May 14, 2021 | May 17, 2021 | May 25, 2021 | May 04, 2021 |
| $0.22 | $0.22 | February 08, 2021 | February 09, 2021 | February 19, 2021 | January 28, 2021 |
| $0.22 | $0.22 | November 23, 2020 | November 24, 2020 | December 04, 2020 | November 12, 2020 |
| $0.22 | $0.22 | August 14, 2020 | August 17, 2020 | August 26, 2020 | August 03, 2020 |
| $0.22 | $0.22 | May 15, 2020 | May 18, 2020 | May 27, 2020 | May 04, 2020 |
Dolby Laboratories News
Read the latest news about Dolby Laboratories, including recent articles, headlines, and updates.
Dolby Laboratories Announces Conference Call and Webcast for Q2 Fiscal 2025 Financial Results
SAN FRANCISCO , April 8, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the second quarter (Q2) fiscal year 2025 after the close of regular trading on Thursday, May 1, 2025. Members of Dolby management will lead a conference call open to all interested parties to discuss Q2 fiscal year 2025 financial results for Dolby Laboratories at 2:00 p.m.
Dolby and AMC Entertainment announce major expansion of Dolby Cinema at AMC in the US, with 40 additional auditoriums to be added by the end of 2027
AMC has also selected Dolby Vision as its HDR offering of choice SAN FRANCISCO and LEAWOOD, Kan. , March 31, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, and AMC Entertainment (NYSE: AMC), the largest theatrical exhibitor in the United States and in the world, today announced a significant expansion of their partnership, following a decade of success and guest popularity of the Dolby Cinema at AMC experience.
Cognition Therapeutics Reports Year End 2024 Financial Results and Provides Business Update
Positive Results with Zervimesine (CT1812) in Phase 2 SHIMMER Dementia with Lewy Bodies (DLB) Phase 2 SHINE Data Show Dramatic Slowing of Cognitive Decline with Zervimesine in a Key Pre-specified Alzheimer's Disease Subgroup 2025 Objective: Advance Zervimesine into Late-stage Trials for DLB and Alzheimer's Disease Management will Review Results at 8:00 a.m. ET on Live Webcast and Conference Call PURCHASE, N.Y.
Our Top 10 Dividend High-Growth Stocks - February 2025
This monthly article focuses on selecting high-growth dividend stocks with rapidly growing dividends rather than high current yields. We use our proprietary models to rate quantitatively and qualitatively and select the top ten names from an initial list of nearly 400 dividend stocks. The final list of ten stocks is chosen based on sector diversity, high-growth quality scores, and positive momentum, suitable for investors in the accumulation phase.
Dolby Laboratories Remains Fully Valued On Slow Growth
Dolby Laboratories reported 13% year-over-year revenue growth in FQ1 2025, mainly due to quarterly timing variations, with a slightly improved fundamental outlook. Dolby's balance sheet includes $521 million in cash and no debt, but stock performance has significantly underperformed the benchmark iShares Expanded Technology-Software ETF. Revenue growth was guided at 3.2% for the current fiscal year, with potential upside in mobile and cinema products, but major catalysts are unlikely.
Compared to Estimates, Dolby Laboratories (DLB) Q1 Earnings: A Look at Key Metrics
The headline numbers for Dolby Laboratories (DLB) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Cognition's Positive Phase 2 ‘SHIMMER' Study of Zervimesine (CT1812) in Dementia with Lewy Bodies (DLB) will be Presented in a Podium Presentation at ILBDC
– Study demonstrated strong therapeutic responses across behavioral, functional, cognitive, and movement measures in patients with mild-to-moderate DLB –
Dolby Laboratories, Inc. (DLB) Q1 2025 Earnings Call Transcript
Dolby Laboratories, Inc. (NYSE:DLB ) Q1 2025 Earnings Conference Call January 29, 2024 5:00 PM ET Company Participants Peter Goldmacher - VP, IR Kevin Yeaman - President, CEO & Director Robert Park - SVP & CFO Conference Call Participants Steven Frankel - Rosenblatt Securities Patrick Sholl - Barrington Research Ralph Schackart - William Blair Operator Ladies and gentlemen, thank you for standing by. Welcome to the Dolby Laboratories Conference Call discussing First Quarter Fiscal Year 2025 results.
Dolby Laboratories Reports First Quarter 2025 Financial Results
SAN FRANCISCO , Jan. 29, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE:DLB) today announced the company's financial results for the first quarter of fiscal 2025. "We are off to a strong start for FY25," said Kevin Yeaman, President and CEO, Dolby Laboratories.
Dolby Laboratories Announces Conference Call and Webcast for Q1 Fiscal 2025 Financial Results
SAN FRANCISCO , Jan. 13, 2025 /PRNewswire/ -- Dolby Laboratories, Inc. (NYSE: DLB), a leader in immersive entertainment experiences, will release financial results for the first quarter (Q1) fiscal year 2025 after the close of regular trading on Wednesday, January 29, 2025. Members of Dolby management will lead a conference call open to all interested parties to discuss Q1 fiscal year 2025 financial results for Dolby Laboratories at 2:00 p.m.
Dolby Revs Up In-Car Entertainment Innovations at CES 2025
Dolby will spotlight its latest innovations in automotive, including an exclusive first look at the latest vehicles to support Dolby Atmos and the world's first car to support Dolby Vision along with Dolby Atmos LAS VEGAS , Jan. 7, 2025 /PRNewswire/ -- Dolby Laboratories, a leader in immersive entertainment experiences, today kicked off the start of the 2025 Consumer Electronics Show (CES) with an exhibition of its latest innovations in automotive. Throughout CES, Dolby will showcase its momentum in automotive through its latest collaborations with leading manufacturers and suppliers, as well as the growing catalog of music, audiobooks, podcasts, and A/V content fueling the catalog of entertainment consumers can enjoy in their vehicles.
Similar Companies
Related Metrics
Explore detailed financial metrics and analysis for DLB.